Literature DB >> 8967342

Molecular cloning and functional expression of a sodium-dicarboxylate cotransporter from human kidney.

A M Pajor1.   

Abstract

The renal Na(+)-dicarboxylate cotransporter reabsorbs Krebs cycle intermediates, such as succinate and citrate, from the glomerular filtrate. The present study describes the cloning and characterization of the human renal Na(+)-dicarboxylate cotransporter, hNaDC-1. The amino acid sequence of hNaDC-1 is 78% identical to the rabbit renal Na(+)-dicarboxylate cotransporter, NaDC-1, and 42% identical to the rat renal Na(+)-sulfate transporter, NaSi-1. The carboxy terminus of hNaDC-1 protein contains two N-glycosylation sites that appear to be utilized. Xenopus oocytes injected with hNaDC-1 cRNA expressed a low-affinity Na(+)-dependent dicarboxylate transporter with Michaelis constant (Km) for succinate around 0.4 mM. The transport of succinate by hNaDC-1 was insensitive to the pH of the medium, whereas the transporter of citrate was stimulated by acidic pH. Northern blot analysis indicates that hNaDC-1 mRNA is found in both kidney and intestine. The gene for hNaDC-1 was localized to chromosome 17. This study provides the first demonstration that the human kidney contains a low-affinity Na(+)-dicarboxylate cotransporter with properties that resemble those of the Na(+)-dicarboxylate cotransporter on the apical membrane of the rabbit renal proximal tubule.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967342     DOI: 10.1152/ajprenal.1996.270.4.F642

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Role of cationic amino acids in the Na+/dicarboxylate co-transporter NaDC-1.

Authors:  A M Pajor; E S Kahn; R Gangula
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

Review 2.  Genes in idiopathic calcium oxalate stone disease.

Authors:  H O Goodman; R Brommage; D G Assimos; R P Holmes
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Fernando Gianfrancesco; Riccardo Muscariello; Michele Schiano di Cola; Pasquale Strazzullo; Teresa Esposito
Journal:  J Nephrol       Date:  2016-09-17       Impact factor: 3.902

4.  Expression of sodium-dependent dicarboxylate transporter 1 (NaDC1/SLC13A2) in normal and neoplastic human kidney.

Authors:  Hyun-Wook Lee; Mary E Handlogten; Gunars Osis; William L Clapp; Dara N Wakefield; Jill W Verlander; I David Weiner
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-07

5.  Molecular and functional analysis of SDCT2, a novel rat sodium-dependent dicarboxylate transporter.

Authors:  X Chen; H Tsukaguchi; X Z Chen; U V Berger; M A Hediger
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Acid Stimulation of the Citrate Transporter NaDC-1 Requires Pyk2 and ERK1/2 Signaling Pathways.

Authors:  Miriam Zacchia; Xuefei Tian; Enrica Zona; Robert J Alpern; Patricia A Preisig
Journal:  J Am Soc Nephrol       Date:  2018-04-20       Impact factor: 10.121

Review 7.  Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters.

Authors:  Ana M Pajor
Journal:  Pflugers Arch       Date:  2005-10-07       Impact factor: 3.657

Review 8.  The SLC13 gene family of sodium sulphate/carboxylate cotransporters.

Authors:  Daniel Markovich; Heini Murer
Journal:  Pflugers Arch       Date:  2003-08-12       Impact factor: 3.657

9.  Threonine-509 is a determinant of apparent affinity for both substrate and cations in the human Na+/dicarboxylate cotransporter.

Authors:  Jittima Weerachayaphorn; Ana M Pajor
Journal:  Biochemistry       Date:  2007-12-28       Impact factor: 3.162

10.  Identification of a gene encoding a transporter essential for utilization of C4 dicarboxylates in Corynebacterium glutamicum.

Authors:  Haruhiko Teramoto; Tomokazu Shirai; Masayuki Inui; Hideaki Yukawa
Journal:  Appl Environ Microbiol       Date:  2008-06-27       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.